Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3876737 | The Journal of Urology | 2008 | 6 Pages |
Abstract
Inflammatory myofibroblastic tumor of the genitourinary tract should be considered a neoplasm of uncertain malignant potential, and routine surveillance and close clinical followup are recommended. Aggressive therapy (radical cystectomy, radiation or chemotherapy) is unwarranted given the indolent and often benign clinical course for the majority of cases. To understand the diagnostic and prognostic implications future emphasis should be placed on the link between genetic abnormalities, and clinical course, therapeutic response and ultimate outcome.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Liang Cheng, Stephanie R. Foster, Gregory T. MacLennan, Antonio Lopez-Beltran, Shaobo Zhang, Rodolfo Montironi,